CCN1: A sticky issue in myeloma

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


In this issue of Blood, Johnson et al report that patients with high CCN1 levels in their marrow who were treated in the Total Therapy 3 trial have a prolonged overall survival and better progression-free survival than patients with lower levels of CCN1.

Original languageEnglish (US)
Pages (from-to)2006-2008
Number of pages3
Issue number13
StatePublished - Sep 25 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'CCN1: A sticky issue in myeloma'. Together they form a unique fingerprint.

Cite this